These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9637748)

  • 1. A universal virus inactivant for decontaminating blood and biopharmaceutical products.
    Brown F; Meyer RF; Law M; Kramer E; Newman JF
    Biologicals; 1998 Mar; 26(1):39-47. PubMed ID: 9637748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A universal virus inactivant for decontaminating blood and biopharmaceutical products.
    Brown F; Meyer RF; Law M; Kramer E; Newman JF
    Dev Biol Stand; 1999; 99():119-30. PubMed ID: 10404883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural differences between foot-and-mouth disease and poliomyelitis viruses influence their inactivation by aziridines.
    Burrage T; Kramer E; Brown F
    Vaccine; 2000 May; 18(22):2454-61. PubMed ID: 10738103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and immunogenicity of experimental foot-and-mouth disease and poliomyelitis vaccines.
    Twomey T; Newman J; Burrage T; Piatti P; Lubroth J; Brown F
    Vaccine; 1995 Nov; 13(16):1603-10. PubMed ID: 8578849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of viruses by aziridines.
    Burrage T; Kramer E; Brown F
    Dev Biol (Basel); 2000; 102():131-9. PubMed ID: 10794100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of acetylethyleneimine upon a strain of inactivated foot-and-mouth disease virus stored at 4 degrees C.
    Staple RF; Morrow AW; Fletton BW
    Arch Virol; 1975; 47(4):331-5. PubMed ID: 166627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binary ethylenimine as an inactivant for foot-and-mouth disease virus and its application for vaccine production.
    Bahnemann HG
    Arch Virol; 1975; 47(1):47-56. PubMed ID: 167679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of human plasma products: polymerase chain reaction does not discriminate between live and inactivated viruses.
    Hilfenhaus J; Gröner A; Nowak T; Weimer T
    Transfusion; 1997 Sep; 37(9):935-40. PubMed ID: 9308641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of viruses in serum with binary ethyleneimine.
    Bahnemann HG
    J Clin Microbiol; 1976 Feb; 3(2):209-10. PubMed ID: 3517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Process scale considerations in evaluation studies and scale-up.
    Walter JK; Werz W; Berthold W
    Dev Biol Stand; 1996; 88():99-108. PubMed ID: 9119169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Binary ethyleneimine as an inactivator of the foot-and-mouth disease virus].
    Tekerlekov P; Veleva E
    Vet Med Nauki; 1985; 22(3):3-8. PubMed ID: 2986348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The inactivation of foot-and-mouth disease virus by ethylethyleneimine and the use of the inactivated virus in the preparation of vaccines].
    Bauer K
    Zentralbl Bakteriol Orig; 1970 Apr; 213(3):285-97. PubMed ID: 4318509
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of temperature and inactivators on strains of foot-and-mouth disease virus in Colombia].
    Gómez GJ; Doel TR
    Rev Latinoam Microbiol; 1984; 26(1):21-6. PubMed ID: 6091209
    [No Abstract]   [Full Text] [Related]  

  • 14. [Curve of inactivation of the aphthous virus with beta-propiolactone. Comparison with other inactivation agents].
    Fayet MT
    Ann Inst Pasteur (Paris); 1967 Feb; 112(2):145-52. PubMed ID: 4291717
    [No Abstract]   [Full Text] [Related]  

  • 15. Equine Rhinitis A Virus Mutants with Altered Acid Resistance Unveil a Key Role of VP3 and Intrasubunit Interactions in the Control of the pH Stability of the Aphthovirus Capsid.
    Caridi F; Cañas-Arranz R; Vázquez-Calvo A; Sobrino F; Martín-Acebes MA
    J Virol; 2016 Nov; 90(21):9725-9732. PubMed ID: 27535044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of foot-and-mouth disease viral sequences in clinical specimens and ethyleneimine-inactivated preparations by the polymerase chain reaction.
    Amaral-Doel CM; Owen NE; Ferris NP; Kitching RP; Doel TR
    Vaccine; 1993; 11(4):415-21. PubMed ID: 8385843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of FMDV RNA amplified by the polymerase chain reaction (PCR).
    Laor O; Torgersen H; Yadin H; Becker Y
    J Virol Methods; 1992 Mar; 36(3):197-207. PubMed ID: 1313822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro surrogate models to aid in the development of antivirals for the containment of foot-and-mouth disease outbreaks.
    Osiceanu AM; Murao LE; Kollanur D; Swinnen J; De Vleeschauwer AR; Lefebvre DJ; De Clercq K; Neyts J; Goris N
    Antiviral Res; 2014 May; 105():59-63. PubMed ID: 24583031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of foot-and-mouth disease virus RNA in clinical samples and cell culture isolates by amplification of the capsid coding region.
    Höfner MC; Carpenter WC; Donaldson AI
    J Virol Methods; 1993 Apr; 42(1):53-61. PubMed ID: 8391540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of methyl glyoxal on infectivity and antigenicity of foot-and-mouth disease virus.
    Ghizatullina NK
    Acta Virol; 1976 Oct; 20(5):380-6. PubMed ID: 11665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.